Combination of GTI-2040 and Cytarabine in the Treatment of Refractory and Relapsed Acute Myeloid Leukemia (AML)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Rebecca B Klisovic, MD
Ohio State University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- San Francisco Veterans Affairs Medical Center
San Francisco, California, United States
- Ucsf Medical Center
San Francisco, California, United States
- Northside Hospital
Atlanta, Georgia, United States
- Indiana Cancer Research Institute
Indianapolis, Indiana, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- the Mount Sinai Hospital
New York, New York, United States
- the Ohio State University
Columbus, Ohio, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2007
- Primary completion
- 30 Sept 2009
- Completion
- 28 Feb 2010
- Last update posted
- 27 Jul 2015
- Registered enrollment
- 27
- Registry id
- NCT00565058
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.